A Quick Refresher on Retatrutide Retatrutide is a synthetic triple-agonist peptide that simultaneously activates three receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
By helping reduce appetite and improve metabolic regulation, Ozempic has become a popular choice for patients seeking effective weight loss solutions
State participation in the Medicaid Drug Rebate Program requires coverage of nearly all FDA-approved drugs for medically accepted indications, but weight-loss drugs are included in a small group of drugs that can be excluded from coverage
Dont rush to the highest dosea sustainable and effective dose is better than the maximum dose if it means you can stick with the treatment
It has been around since 1959, making it one of the longest-standing FDA-approved weight loss medications in the United States
Patients should inform the scheduling coordinator and procedural team about all medications, including GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists, with specific drug name, dose, and frequency
